HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of Xenobiotic Biomarkers CYP1 Family in Preputial Tissue of Patients with Hypospadias and Phimosis and Its Association with DNA Methylation Level of SRD5A2 Minimal Promoter.

Abstract
Several epidemiological studies have suggested that the incidence of male reproductive organ malformations, including hypospadias or cryptorchidism, has increased due to fetal-stage exposure to environmental pollutants. However, the association of chemical exposure with the expression of target regulatory genes in the tissues of patients has not yet been reported. Because experimental approaches or clinical trials in human studies are limited, especially those using fetal and/or infants, it is difficult to obtain clear physiological evidence of mechanisms underlying male reproductive malformations. Thus, the lack of physiological evidence makes this issue controversial. We analyzed preputial tissues from patients with hypospadias (n = 23) and phimosis (n = 16). The atypical CYP1 family genes, CYP1A1 and CYP1B1, are potential biomarkers of environmental chemical exposure. We then compared the expression levels of CYP1A1 and CYP1B1 between hypospadias and phimosis samples by quantitative RT-PCR analysis. The mRNA expression levels of SRD5A2 and AR also were measured, because the androgen-related genes involved in the onset of disorders of male reproductive system. A significantly higher CYP1B1 expression level and a lower AR expression level were observed in the hypospadias groups than in the phimosis group. Positive correlations (P < 0.001) between the mRNA expression levels of the CYP1 family and SRD5A2 were found in patients with hypospadias but not in those with phimosis. Moreover, the methylation levels of the four genes were determined by bisulfite genomic sequencing. Although the SRD5A2 promoter region showed moderate methylation, no methylation was detected in CYP1A1, CYP1B1, or AR. There was no significant difference in SRD5A2 promoter methylation level between hypospadias and phimosis patients. Negative correlations were found between the methylation level of SRD5A2, especially at the - 221 Sp1 site, and the CYP1 family mRNA expression levels (CYP1A1, p = 0.002; CYP1B1, p = 0.007) in hypospadias patients, but not in phimosis patients. The significant positive association of mRNA expression level and the negative association of methylation level of the SRD5A2 gene with the mRNA expression levels of CYP1 family genes in the preputial tissue seem to indicate the chemical exposure of patients with hypospadias.
AuthorsSeiichiroh Ohsako, Toshiki Aiba, Mami Miyado, Maki Fukami, Tsutomu Ogata, Yutaro Hayashi, Kentaro Mizuno, Yoshiyuki Kojima
JournalArchives of environmental contamination and toxicology (Arch Environ Contam Toxicol) Vol. 74 Issue 2 Pg. 240-247 (Feb 2018) ISSN: 1432-0703 [Electronic] United States
PMID29080015 (Publication Type: Journal Article)
Chemical References
  • AR protein, human
  • Biomarkers
  • Membrane Proteins
  • RNA, Messenger
  • Receptors, Androgen
  • Xenobiotics
  • CYP1A1 protein, human
  • CYP1B1 protein, human
  • Cytochrome P-450 CYP1A1
  • Cytochrome P-450 CYP1B1
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase
  • SRD5A2 protein, human
Topics
  • 3-Oxo-5-alpha-Steroid 4-Dehydrogenase (genetics)
  • Adolescent
  • Biomarkers (metabolism)
  • Child
  • Child, Preschool
  • CpG Islands
  • Cytochrome P-450 CYP1A1 (genetics)
  • Cytochrome P-450 CYP1B1 (genetics)
  • DNA Methylation
  • Foreskin
  • Humans
  • Hypospadias (genetics)
  • Infant
  • Male
  • Membrane Proteins (genetics)
  • Phimosis (genetics)
  • Promoter Regions, Genetic
  • RNA, Messenger (metabolism)
  • Receptors, Androgen (genetics)
  • Xenobiotics (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: